HPV SPECIFIC IMMUNOTHERAPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA USING VGX-3100 INDUCES REGRESSION OF CERVICAL LESIONS AND POTENT T-CELL RESPONSES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY

MORROW, M.. (2015). HPV SPECIFIC IMMUNOTHERAPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA USING VGX-3100 INDUCES REGRESSION OF CERVICAL LESIONS AND POTENT T-CELL RESPONSES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY. CANCER RESEARCH, 75(15), 0-0. SID. https://sid.ir/paper/705263/en

MORROW M.. HPV SPECIFIC IMMUNOTHERAPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA USING VGX-3100 INDUCES REGRESSION OF CERVICAL LESIONS AND POTENT T-CELL RESPONSES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY. CANCER RESEARCH[Internet]. 2015;75(15):0-0. Available from: https://sid.ir/paper/705263/en

M. MORROW, “HPV SPECIFIC IMMUNOTHERAPY FOR CERVICAL INTRAEPITHELIAL NEOPLASIA USING VGX-3100 INDUCES REGRESSION OF CERVICAL LESIONS AND POTENT T-CELL RESPONSES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY,” CANCER RESEARCH, vol. 75, no. 15, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/705263/en